livanova Archives - Cardiovascular News

Perceval sutureless valve data presented at EACTS 2020

14th October 2020

LivaNova has announced ne...

COVID-19: LivaNova can modify indications of its cardiopulmonary products to help address virus

24th April 2020

LivaNova has announce...

Positive results for LivaNova’s Perceval sutureless valve

23rd January 2019

Three newly published...

PRECLUDE study of Caisson TMVI system concludes

8th August 2018

LivaNova has announced th...

LivaNova to buy TandemLife

15th February 2018

LivaNova has entered into...

Optiflow arterial cannulae family launched onto the USA

26th September 2017

LivaNova has received...

New literature review highlights that Perceval sutureless aortic valve is safe

12th September 2017

Corey Adams (Health S...

LivaNova’s Perceval sutureless valve awarded Centers for Medicare and Medicaid add-on payment

11th August 2017

LivaNova’s Perceval s...

LivaNova acquires Caisson Interventional

5th May 2017

LivaNova has announced it...

New data reaffirms value of Perceval for aortic valve replacement in aortic stenosis patients

5th May 2017

LivaNova has announce...

LivaNova to delist from London Stock Exchange

3rd March 2017

LivaNova has applied for ...

Write to us
Editorial: Will Date will@bibamedical.com
Advertising: Hannah Shiels hannah@bibamedical.com

United Kingdom:

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

United States:

BIBA Medical, North America
155 North Wacker Drive, Suite 4250, Chicago, IL 60606
TEL: +1 949 723 9309
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy